A Study of the Response of Elderly Patients with End-Stage Renal Disease to Epoetin Alfa or Beta

ISSN： 1170-229X

Source： Drugs & Aging, Vol.21, Iss.3, 2004-01, pp. : 187-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics of Rosiglitazone in Patients with End-stage Renal Disease

By Thompson-Culkin K Zussman B Miller AK Freed MI

The Journal of International Medical Research, Vol. 30, Iss. 4, 2002-07 ,pp. : 391-399

Field House Publishing

Access to resources Recommend Favorite

Pharmacokinetics and Blood Pressure Response of Losartan in End-Stage Renal Disease

By Sica D.A.

Clinical Pharmacokinetics, Vol. 38, Iss. 6, 2000-06 ,pp. : 519-526

Adis International

Access to resources Recommend Favorite

Epidemiology of end-stage renal disease

By Roderick Paul

Clinical Medicine, Vol. 2, Iss. 3, 2002-05 ,pp. : 200-204

Royal College Of Physicians

Access to resources Recommend Favorite

Pathophysiology and Treatment of Hyperhomocysteinemia in End‐Stage Renal Disease Patients

Hemodialysis International, Vol. 5, Iss. 1, 2001-01 ,pp. : 86-91

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pleiotropic Effects of Sevelamer Beyond Phosphate Binding in End-Stage Renal Disease Patients: A Randomized, Open-Label, Parallel-Group Study

By Lin Yu-Feng Chien Chiang-Ting

Clinical Drug Investigation, Vol. 31, Iss. 4, 2011-04 ,pp. : 257-267

Adis International

Access to resources Recommend Favorite